Innovative MedTech Inc.
IMTH · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | -6.1% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | 96.9% | 96.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $1 | $1 | $4 |
| SG&A Expenses | $0 | $1 | $1 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | -$0 | $0 |
| Operating Expenses | $0 | $1 | $1 | $4 |
| Operating Income | -$0 | -$1 | -$1 | -$3 |
| % Margin | – | – | -193.1% | -672.5% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$4 |
| Pre-Tax Income | -$0 | -$1 | -$1 | -$7 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$1 | -$1 | -$7 |
| % Margin | – | – | -206.4% | -1,462.9% |
| EPS | -0.002 | -0.036 | -0.032 | -0.28 |
| % Growth | 95.3% | -14.1% | 88.6% | – |
| EPS Diluted | -0.002 | -0.036 | -0.032 | -0.28 |
| Weighted Avg Shares Out | 53 | 31 | 28 | 24 |
| Weighted Avg Shares Out Dil | 53 | 31 | 28 | 24 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$1 | -$1 | -$7 |
| % Margin | – | – | -191.2% | -1,446.7% |